Daré Bioscience, Inc. (DARE)
0.6575
+0.01
(+2.13%)
USD |
NASDAQ |
Oct 27, 16:00
0.6575
0.00 (0.00%)
After-Hours: 20:00
Daré Bioscience Free Cash Flow : -11.76M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -11.76M |
| March 31, 2026 | -10.16M |
| December 31, 2025 | -10.27M |
| September 30, 2025 | -17.15M |
| June 30, 2025 | -3.906M |
| March 31, 2025 | -5.470M |
| September 30, 2024 | -8.629M |
| June 30, 2024 | -10.98M |
| March 31, 2024 | -30.20M |
| December 31, 2023 | -39.49M |
| September 30, 2023 | -36.60M |
| June 30, 2023 | -20.06M |
| March 31, 2023 | -21.92M |
| December 31, 2022 | -18.15M |
| September 30, 2022 | -22.17M |
| June 30, 2022 | -29.41M |
| March 31, 2022 | -32.75M |
| December 31, 2021 | -28.78M |
| September 30, 2021 | -28.06M |
| June 30, 2021 | -34.72M |
| March 31, 2021 | -27.03M |
| December 31, 2020 | -25.25M |
| September 30, 2020 | -19.87M |
| June 30, 2020 | -17.69M |
| Date | Value |
|---|---|
| March 31, 2020 | -16.60M |
| December 31, 2019 | -13.32M |
| September 30, 2019 | -12.22M |
| June 30, 2019 | -11.79M |
| March 31, 2019 | -11.47M |
| December 31, 2018 | -10.28M |
| September 30, 2018 | -8.531M |
| June 30, 2018 | -7.196M |
| March 31, 2018 | -4.608M |
| December 31, 2017 | -2.540M |
| September 30, 2017 | -3.490M |
| June 30, 2017 | -9.258M |
| March 31, 2017 | -20.50M |
| December 31, 2016 | -34.07M |
| September 30, 2016 | -40.51M |
| June 30, 2016 | -41.32M |
| March 31, 2016 | -37.84M |
| December 31, 2015 | -32.19M |
| September 30, 2015 | -29.56M |
| June 30, 2015 | -27.20M |
| March 31, 2015 | -23.58M |
| December 31, 2014 | -19.29M |
| September 30, 2014 | -16.84M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Elite Pharmaceuticals, Inc. | 17.53M |
| Eton Pharmaceuticals, Inc. | -0.268M |
| ANI Pharmaceuticals, Inc. | 167.52M |
| Corcept Therapeutics, Inc. | 106.92M |
| Veru, Inc. | -26.04M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -6.775M |
| Cash from Investing (Quarterly) | -0.0806M |
| Cash from Financing (Quarterly) | 0.9512M |
| Free Cash Flow Per Share (Quarterly) | -0.4604 |
| Free Cash Flow to Equity (Quarterly) | -6.436M |
| Free Cash Flow to Firm (Quarterly) | -6.665M |
| Free Cash Flow Yield | -126.2% |